OCT 11, 2018 1:30 PM PDT

Breast Cancer as a Global Disease: Are We Up to The Challenge?

Speaker
  • Professor of Surgery, Division of General Surgery (Surgical Oncology Section), University of Washington School of Medicine
    Biography
      Dr. Anderson's is an internationally recognized leader in global cancer control. With joint appointments at the Fred Hutchinson Cancer Research Center Division of Public Health Sciences and the UW Department of Global Health, Dr. Anderson created in 2002 and continues to chair the Breast Health Global Initiative (BHGI), a unique program to develop "resource-stratified" guidelines for breast cancer early detection, diagnosis, treatment and palliative care in low- and middle-income countries (LMICs). In 2011 the American Society of Clinical Oncology (ASCO) awarded Dr. Anderson their Partners in Progress Award and in 2013 the National Consortium of Breast Centers (NCBC) awarded him their 2013 Inspiration Award, recognizing his dedicated efforts to improve the quality and effectiveness of breast cancer care around the globe. Since 2012, Dr. Anderson has served on the Board of Directors of the Union for International Cancer Control (UICC). Dr. Anderson now co-chairs the Breast Cancer Initiative 2.5 (BCI2.5), a global campaign to reduce disparities in breast cancer outcomes for 2.5 million women between now and 2025.

    Abstract

    As the most common female malignancy, breast cancer is the most likely reason that a woman will die of cancer around the world. Breast cancer mortality has dropped in the U.S. by 35% since 1990 due to improved early detection and timely treatment.  By contrast, most breast cancer deaths occur in low and middle income countries (LMICs).  The Breast Health Global Initiative (BHGI) developed resource-stratified guidelines as a framework for breast cancer management in limited resource environments.  Pilot studies from Latin America, Asia and sub-Saharan Africa use implementation research methods to demonstrate best practices that improve outcome despite resource constraints. “Phased implementation” is a novel approach to guide strategic program development to save breast cancer lives.

    Learning Objectives: 

    1. Understand why breast cancer mortality has dropped in the U.S. by 35% since 1990
    2. Understand why breast cancer is the most likely reason that a woman will die of cancer around the world


    Show Resources
    You May Also Like
    DEC 02, 2020 8:00 AM PST
    C.E. CREDITS
    DEC 02, 2020 8:00 AM PST
    DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...
    OCT 08, 2020 7:00 AM PDT
    C.E. CREDITS
    OCT 08, 2020 7:00 AM PDT
    DATE: October 8, 2020 TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop thinking about ho...
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    AUG 25, 2020 8:00 AM PDT
    C.E. CREDITS
    AUG 25, 2020 8:00 AM PDT
    DATE: August 25, 2020 TIME: 8:00am PDT, 10:00am CDT, 11:00am EDT Recombinant lentivirus (LV) and adeno-associated virus (AAV) are critical components of cell and gene therapies, which show g...
    OCT 29, 2020 6:00 AM PDT
    C.E. CREDITS
    OCT 29, 2020 6:00 AM PDT
    Date: October 29, 2020 Time: 6:00am (PDT), 9:00am (EDT), Chronic inflammation can occur as a result of a combination of genetic predispositions and environmental factors. Epigenetic modifica...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    OCT 11, 2018 1:30 PM PDT

    Breast Cancer as a Global Disease: Are We Up to The Challenge?


    Specialty

    Cancer Research

    Genetics

    Cancer

    Cancer Diagnostics

    Gene Expression

    Oncology

    Dna

    Biomarkers

    Cell

    Animal Models

    Molecular Biology

    Antibodies

    Disease

    Animal Sciences

    Drug Development

    Geography

    North America55%

    Asia27%

    Europe18%

    Registration Source

    Website Visitors100%

    Job Title

    Student33%

    Pharmacist11%

    Clinical Laboratory Scientist11%

    Executive11%

    Medical Doctor/Specialist11%

    Research Scientist11%

    Medical Laboratory Technician11%

    Organization

    Hospital27%

    Academic Institution18%

    Research Institute9%

    Biotech Company9%

    Contract Research Organization (Cro)9%

    Medical Center9%

    Other18%


    Show Resources
    Loading Comments...
    Show Resources
    Attendees
    • See more